A novel B-CLL specific nuclear protein (p44/46)

Leukemia Research

Volumn 23, Issue 9, 1999, Pages 833-841

  Chruściel, Joanna ^a   Bloński, Jerzy ^b   Szymczyk, Piotr ^a   Robak, Tadeusz ^b   Kiliańska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

B CLL; B CLL progression; Cellular fractions; Lymphoid leukemias; Neoplastic marker; Proteins

Indexed keywords

NUCLEAR PROTEIN; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CYTOCHEMISTRY; ELECTROPHORESIS; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL SEPARATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 0345280810     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00100-9     Document Type: Article

References (52)

1. Hamblin T.J., Oscier D.G. Chronic lymphocytic leukaemia: the nature of the leukaemic cell. Blood Reviews. 11:1997;119.
2. Galton D.A.G. B-chronic lymphocytic leukemia: some diagnostic and clinical aspects. Polliack A., Catovsky D. Chronic Lymphocytic Leukemia. 1988;33 Harwood Academic Publishing, GmbH Chur, Switzerland.
3. Avila-Carino J., Lewin N., Tomita Y, Szeles A., Sandlund A., Mosolits S. et al. B-CLL cells with unusual properties. Int. J. Cancer. 70:1997;1.
4. Rozman C., Bosch F., Montserrat E. Chronic lymphocytic leukemia: a changing natural history? Leukemia. 11:1997;775.
5. Gardiner A.C., Corcoran M.M., Oscier D.G. Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13ql4 in chronic lymphocytic leukemia. Genes, Chromosomes and Cancer. 20:1997;73.
6. McKeithan T.W., Tatimoto G.S., Ohno H., Bjorling V.S., Morgan R., Hecht B.H. et al. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes, Chromosomes and Cancer. 20:1997;64.
7. Wahbi K., Hayette S., Callanan M., Gadoux M., Charrin C., Magaud J.P. et al. Involvement of a human endogenous retroviral sequence (THE-7) in a t(7;14)(q21;q32) chromosomal translocation associated with a B cell chronic lymphocytic leukemia. Leukemia. 11:1997;1214.
8. Faguet G.B., Agee J.F. Monoclonal antibodies against the chronic lymphatic leukemia antigen cCLLa: characterization and reactivity. Blood. 70:1987;437.
9. Faguet G.B. Chronic lymphocytic leukemia: an updated review. J. Clin. Oncol. 12:1994;1974.
10. Gazitt Y, Polliack A. Characterization of GP-70: a novel B-cell leukemia specifc antigen and the correlation between GP-70 expression and disease activity. Polliack A., Catovsky D. Chronic Lymphocytic Leukemia. 1988;325 Harwood Academic Publishing, GmbH Chur, Switzerland.
11. Saunders F.K., Sharrard R.M., Winfield D.A., Lawiy J., Goepel J.R., Hancock B.W. et al. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes. Leukemia Res. 12:1993;223.
12. Saunders F.K., Winfield D.A., Goepel J.R., Hancock B.W., Sharrard R.M., Goyns M.H. 2D-gel analysis of protein synthesis profiles of different stages of chronic lymphocytic leukaemia. Leukemia Lymphoma. 14:1994;319.
13. Csanaky G., Matutes E., Uass J.A., Morilla R., Catovsky D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia. 11:1997;408.
14. De Rossi G., Marroni P., Paganuzzi M., Mauro F.R., Tenca C., Zarcone D. et al. Increased serum level of soluble CD44 standard, but not of variant isoforms v5 and v6, in B-cell chronic lymphocytic leukemia. Leukemia. 11:1997;134.
15. Chruściel J., Bloński J., Krykowski E., Mirowski M., Hanausek M., Kiliańska Z.M. Characterization of proteins from chronic lymphocytic leukaemic cells; electrophoretic and immunological approach. Cytobios. 85:1996;39.
16. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternak B.S. Clinical staining of chronic lymphocytic leukemia. Blood. 46:1975;219.
17. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21:1968;77.
18. Bennett J.M., Catovsky D., Daniel M.-T., Flandrin G., Galton D.A.Y., Gralnick H.R., Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid malignancies. J. Clin. Pathol. 92:1989;567.
19. Blobel G., Potter U.R. Nuclei from rat liver: isolation, method that combines purity with high yield. Science. 154:1966;1662.
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
21. Wray W, Boulikas T., Wray V.P., Hancock R. Silver staining of proteins in polyacrylamide gels. Analyt. Biochem. 118:1981;197.
22. Fairbanks G., Steck T.L., Wallach D.F.H. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 10:1971;2606.
23. Towbin H., Staechelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350.
24. Leary J.J., Brigati J.J., Ward D.C. Rapid and sensitive colorimetric method for visualizing biotinlabelled DNA probes hybrized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc. Natl. Acad. Sci. USA. 80:1983;4045.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
26. Kiliañska Z., Schmidt W.N., Hnilica L.S. Antibodies to dehistonized chromatin of normal and fetal rat liver. Cell Differ. 13:1983;225.
27. Dinh B.-L., Tremblay M., Paradis D., Ray P.E., Tetu B. Generation of monoclonal antibodies reactive with nuclear proteins of human primary breast tumors. Int. J. Cancer. 41:1988;201.
28. Kallajoki M., Osborn M. Gel electrophoretic analysis of nuclear matrix fractions isolated from different human cell lines. Electrophoresis. 15:1994;520.
29. Keesee S.K., Meneghini M.D., Szaro R.P., Wu Y.J. Nuclear matrix proteins in human colon cancer. Proc. Natl. Acad. Sci. USA. 91:1994;1913.
30. Keesee S.K., Briggman J.V., Thill G., Wu Y.J. Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukary Gene Exp. 6:1996;189.
31. Szymczyk P., Krajewska W.M., Jakubik J., Berner A., Janczukowicz, Mikulska U., Berner J., Kiliańska Z.M. Molecular characterization of cellular proteins from colorectal tumors. Tumori. 82:1996;376.
32. Wang D., Freeman G.J., Levine H., Ritz J., Robertson J. Role of the CD4O and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br. J. Haemat. 97:1997;409.
33. Estanol J.M., Agell N., Bachs O. Nuclear protein pattern in normal T-lymphocytes and lymphoblastoid cells. Cancer Res. 57:1997;55.
34. De Rosi G., Zarcona D., Mauro F., Cerruti G., Tenca C., Puccetti A. et al. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets. Blood. 81:1993;2679.
35. Hanausek M., Wang S.C., Bloński J., Polkowska-Kulesza E., Walaszek Z., Mirowski M. Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias. Int. J. Haemat. 63:1996;193.
36. Wolowiec D., Benchaib M., Pernas P., Deviller P., Souchier C., Rimokh R. et al. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia. 9:1995;1382.
37. Del Giglio A., O'Brien S., Ford R., Saya H., Manning J., Keating M. et al. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood. 79:1992;2717.
38. De Melo N., Matutes E., Cordone I., Morilla R., Catovsky D. Expression of Ki-67 nuclear antigen in B and T cell limphoproliferative disorders. J. Clin. Path. 45:1992;660.
39. Inoue T., Yamane T., Park K., Im T., Tatsumi N., Okuda K. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies. Arch. Path. Lab. Med. 117:1993;969.
40. Sabattini E., Gerdes J., Gherlinzoni F., Poggi S., Zucchini L., Falini B. et al. Comparison between the monoclonal antibodies Ki-67 and PC 10 in 125 malignant lymphomas. J. Pathol. 169:1993;397.
41. Look A.T. Oncogenic role of 'master' transcription factors in human leukemias and sarcomas: a developmental model. Adv. Can. Res. 67:1995;25.
42. Menssen H.D., Renkl H.-J., Rodeck U., Maurer J., Notter M., Schwartz S. et al. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia. 9:1995;1060.
43. Rabbits T.H. Translocations, master genes, and different between the origins of acute and chronic leukemias. Cell. 67:1991;641.
44. Binet J.L., Auguier A., Dighiero G., Chastang C., Piguet H., Goasguen J. et al. A new prognosic classification of chronic lymphocytic leukemia derived from a multivariate analysis. Cancer. 48:1981;198.
45. Montserrat E., Sanchez-Bisono J., Vinolas N., Rozman C. Lymphocyte doubling time in chronic lymphocytic leukemia: analysis of its prognostic significance. Br. J. Haemat. 62:1986;567.
46. Uallespi T., Montserrat E., Sancz M.A. Chronic lymphocytic leukemia: prognostic value of lymphocyte morphological subtypes. A multivariate analysis in 146 patients. Br. J. Haemat. 77:1991;478.
47. Simonsson B., Wibell L., Nilsson K. β2-microgolulin in chronic lymphocytic leukemia. Scand. J. Haemat. 24:1980;174.
48. Kallander C.F.R., Simonsson B., Hagberg H., Gronowitz J.S. Serum deoxythymidine kinase gives prognostic information in CLL. Cancer. 54:1984;2450.
49. Van Oers M.H.J., Pals S.T., Evers L.M., Van der Schoot C.E., Koopman G., Bonfrer J.M.G. et al. Expression and release of CD27 in human B-cell malignancies. Blood. 82:1993;3430.
50. Christiansen I., Gidlof C., Wallgren A.C., Simonsson B., Totterman T.H. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stages and prognostic markers. Blood. 84:1994;3010.
51. Wang S., Mirowski M., Sherman U., Walaszek Z., Hanausek M. Monoclonal antibodies against a novel 65-kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma. 12:1993;167.
52. Brandt-Rauf P.W., Pincus M.R. Molecular markers of carcinogenesis. Pharmacol. Ther. 77:1998;135.